CEBU, Philippines - The Ayala Center Cebu (ACC ... ACC division head Clavel Tongco said that the Phase-II-B project, which cost the company an investment of over P2 billion already, will have ...

The RINGSIDE pivotal Phase 2/3 study is a randomized global multi-center trial, with a seamless design, allowing Ayala to continue to Phase 3 without concluding the Phase 2 segment. The Phase 2 ...

After the completion of the lagoon development of Ayala Center Cebu, which is expected ... Monera, he said that the Phase 2-B project will be pursued by the company next year, starting with ...

--(BUSINESS WIRE)--Ayala Pharmaceuticals ... AL101 Phase 2 Trial in Patients with ACC ACCURACY is a Simon 2-Stage optimal design, non-comparative, open-label, single-arm, multi-center study ...

Phase 2b data show OST-HER2 significantly improved ... programs and related intellectual property (IP) assets from Ayala Pharmaceuticals. OS Therapies will pay $0.5 million in cash and issue ...

today recognized the announcement by Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, that patient enrollment has been completed in the Phase 3 RINGSIDE study ...

Miriam Katigbak, head of Ayala Land's strategic landbank management said even its strategic Ayala Center development will soon be housing BPO office spaces. "There will be BPO offices and hotels above ...